Prognostic Efficacy of the Albumin Grade in Patients with Hepatocellular Carcinoma.
Hirano Y, Nouso K, Kariyama K, Hiraoka A, Shiota S, Wakuta A, Yasuda S, Toyoda H, Tsuji K, Hatanaka T, Kakizaki S, Naganuma A, Tada T, Itobayashi E, Ishikawa T, Shimada N, Takaguchi K, Tsutsui A, Nagano T, Imai M, Nakamura S, Kumada T; Real-Life Practice Experts for HCC (RELPEC) Study Group in Japan.
Hirano Y, et al. Among authors: yasuda s.
Acta Med Okayama. 2024 Oct;78(5):377-386. doi: 10.18926/AMO/67662.
Acta Med Okayama. 2024.
PMID: 39467656
Free article.